Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

FSTR

L.B. Foster Co

Dec 05 • 04:00PM ET

27.01

+0.25 0.93 %

Industrials • Railroads • USA • NASD

Peers: UNP NSC CSX WAB CNI CP TRN GBX GATX RAIL

| Held by: VTI IWM VXF IWN DFAT AVUV VTWO DFSV DFAS IWC

Index	RUT	P/E	60.97	EPS (ttm)	0.44	Insider Own	8.60%	Shs Outstand	10.25M	Perf Week	0.11%
Market Cap	280.72M	Forward P/E	14.92	EPS next Y	1.81	Insider Trans	-6.17%	Shs Float	9.50M	Perf Month	-2.81%
Enterprise Value	362.51M	PEG	-	EPS next Q	0.66	Inst Own	76.05%	Short Float	1.55%	Perf Quarter	-0.66%
Income	4.89M	P/S	0.55	EPS this Y	-71.12%	Inst Trans	-1.98%	Short Ratio	5.86	Perf Half Y	39.80%
Sales	507.82M	P/B	1.58	EPS next Y	61.13%	ROA	1.44%	Short Interest	0.15M	Perf YTD	0.41%
Book/sh	17.06	P/C	81.84	EPS next 5Y	-18.70%	ROE	2.74%	52W High	29.77 -9.29%	Perf Year	-8.29%
Cash/sh	0.33	P/FCF	10.13	EPS past 3/5Y	125.90% -1.01%	ROIC	1.89%	52W Low	17.16 57.40%	Perf 3Y	186.73%
Dividend Est.	-	EV/EBITDA	11.52	Sales past 3/5Y	1.10% -2.95%	Gross Margin	21.27%	Volatility	2.75% 3.44%	Perf 5Y	85.51%
Dividend TTM	-	EV/Sales	0.71	EPS Y/Y TTM	-88.11%	Oper. Margin	3.63%	ATR (14)	0.97	Perf 10Y	115.91%
Dividend Ex-Date	Sep 07, 2016	Quick Ratio	1.21	Sales Y/Y TTM	-5.51%	Profit Margin	0.96%	RSI (14)	52.22	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.21	EPS Q/Q	-87.75%	SMA20	0.89%	Beta	1.00	Target Price	29.50
Payout	0.00%	Debt/Eq	0.48	Sales Q/Q	0.60%	SMA50	1.04%	Rel Volume	0.67	Prev Close	26.76
Employees	1057	LT Debt/Eq	0.48	Earnings	Nov 03 BMO	SMA200	16.09%	Avg Volume	25.13K	Price	27.01
IPO	Jun 09, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	-34.43% -9.97%	Trades		Volume	16,790	Change	0.93%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-27-25	Resumed	B. Riley Securities	Neutral	$25
Jun-06-22	Downgrade	B. Riley Securities	Buy → Neutral	$18 → $14
Jun-09-20	Resumed	B. Riley FBR	Buy	$18
Mar-06-19	Initiated	B. Riley FBR	Buy	$25
May-04-16	Downgrade	DA Davidson	Buy → Neutral	$20 → $18
Sep-11-15	Downgrade	Macquarie	Outperform → Neutral
Mar-04-15	Downgrade	Stifel	Buy → Hold
Jan-06-15	Reiterated	Stifel	Buy	$58 → $60
Jun-03-14	Reiterated	Stifel	Buy	$52 → $56
Aug-07-13	Upgrade	Stifel	Hold → Buy	$49
Jan-11-13	Initiated	Stifel Nicolaus	Hold

Show Previous Ratings

Dec-03-25 10:40AM	L.B. Foster Company to Present Virtually at Sidoti's Year-End Conference on December 10, 2025, and at Singular Research's Best of the Uncovereds Conference on December 11, 2025 (GlobeNewswire)
Nov-10-25 12:33AM	5 Insightful Analyst Questions From L.B. Foster's Q3 Earnings Call (StockStory)
Nov-04-25 12:32AM	FSTR Q3 Deep Dive: Backlog Growth and Rail Deferrals Shape Year-End Outlook (StockStory)
Nov-03-25 04:00PM	L.B. Foster Co (FSTR) Q3 2025 Earnings Call Highlights: Strong Backlog and Cash Flow Amidst ... (GuruFocus.com)
01:15PM	Why L.B. Foster (FSTR) Stock Is Down Today (StockStory)
07:39AM	Loading…
07:39AM	L.B. Foster (NASDAQ:FSTR) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
07:38AM	L.B. Foster: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	L.B. Foster Announces Continuing Sales Growth and Robust Cash Generation in Fiscal Third Quarter with Expected Strong Finish to 2025 (GlobeNewswire)
Nov-01-25 11:09PM	L.B. Foster (FSTR) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-31-25 09:32AM	L.B. Foster Co (FSTR) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-29-25 12:33AM	3 Small-Cap Stocks We're Skeptical Of (StockStory)
Oct-27-25 05:40PM	Nucor (NUE) Q3 Earnings and Revenues Beat Estimates (Zacks)
01:00PM	L.B. Foster Company to Report Third Quarter 2025 Results on November 3, 2025 (GlobeNewswire)
Oct-20-25 07:15AM	Cleveland-Cliffs (CLF) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Oct-17-25 12:29PM	Commercial Metals Q4 Earnings Beat Estimates, Sales Rise Y/Y (Zacks)
12:38AM	Loading…
Sep-25-25 12:38AM	2 Volatile Stocks for Long-Term Investors and 1 We Brush Off (StockStory)
Sep-16-25 11:20AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Sep-11-25 01:00PM	L.B. Foster Company to Present Virtually at Sidoti Small Cap Conference on September 18, 2025 (GlobeNewswire)
Sep-05-25 02:20PM	Why L.B. Foster (FSTR) Shares Are Trading Lower Today (StockStory)
Sep-01-25 12:02AM	3 Reasons to Sell FSTR and 1 Stock to Buy Instead (StockStory)
Aug-31-25 04:19PM	L B Foster Co (FSTR) Delivers First 320-Foot Rail Train to Lake State Railway (Insider Monkey)
Aug-22-25 12:35AM	3 Cash-Producing Stocks Walking a Fine Line (StockStory) +9.40%
Aug-20-25 01:00PM	L.B. Foster Company to Present at Three Part Advisors' Midwest IDEAS Investor Conference on August 27, 2025, in Chicago, IL (GlobeNewswire)
Aug-18-25 01:33AM	The Top 5 Analyst Questions From L.B. Foster's Q2 Earnings Call (StockStory)
Aug-14-25 11:35PM	Q2 Earnings Highs And Lows: L.B. Foster (NASDAQ:FSTR) Vs The Rest Of The General Industrial Machinery Stocks (StockStory)
Aug-12-25 03:04AM	L.B. Foster Co (FSTR) Q2 2025 Earnings Call Highlights: Strategic Execution Drives EBITDA ... (GuruFocus.com)
01:31AM	FSTR Q2 Deep Dive: Infrastructure Segment Growth Offsets Rail Weakness, Guidance Adjusted (StockStory)
Aug-11-25 07:30PM	L.B. Foster (FSTR) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:55PM	L.B. Foster (FSTR) Q2 Earnings and Revenues Miss Estimates (Zacks)
06:07PM	L.B. Foster: Q2 Earnings Snapshot (Associated Press Finance)
03:50PM	Loading…
03:50PM	L.B. Foster (FSTR) Shares Skyrocket, What You Need To Know (StockStory)
07:51AM	L.B. Foster (NASDAQ:FSTR) Posts Q2 Sales In Line With Estimates, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:30AM	L.B. Foster Announces Strong Second Quarter Results with Organic Growth and Profitability Expansion Expected to Continue Through Balance of 2025 (GlobeNewswire)
Aug-09-25 11:03PM	L.B. Foster Earnings: What To Look For From FSTR (StockStory)
Aug-08-25 09:27AM	What To Expect From L.B. Foster Co (FSTR) Q2 2025 Earnings (GuruFocus.com)
Aug-07-25 08:11AM	Barrick Mining to Post Q2 Earnings: What's in the Cards for the Stock? (Zacks)
Aug-06-25 07:35PM	Hecla Mining (HL) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 09:10AM	L.B. Foster Company to Report Second Quarter 2025 Results on August 11, 2025 (GlobeNewswire)
Jul-29-25 06:40PM	Algoma Steel Group Inc. (ASTL) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
10:00AM	L.B. Foster (FSTR) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-28-25 05:40PM	Nucor (NUE) Q2 Earnings Miss Estimates (Zacks)
Jul-17-25 08:46AM	Do Options Traders Know Something About L.B. Foster Stock We Don't? (Zacks)
Jul-10-25 12:34AM	3 Profitable Stocks Facing Headwinds (StockStory)
Jul-01-25 08:35AM	L.B. Foster Increases Borrowing Capacity & Extends Maturity Date (Zacks)
Jun-30-25 04:00PM	L.B. Foster Company Completes Successful Amendment to its Revolving Credit Agreement (GlobeNewswire)
Jun-26-25 06:05PM	5 Revealing Analyst Questions From L.B. Foster's Q1 Earnings Call (StockStory)
Jun-25-25 12:03AM	3 Reasons to Sell FSTR and 1 Stock to Buy Instead (StockStory)
Jun-20-25 12:31AM	3 Russell 2000 Stocks in the Doghouse (StockStory)
Jun-06-25 11:30AM	Cleveland-Cliffs (CLF) Down 0.7% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-05-25 11:26AM	L.B. Foster Company to Present at Three Part Advisors' East Coast IDEAS Investor Conference on June 12, 2025, in New York, NY (GlobeNewswire)
Jun-02-25 11:36PM	Q1 Rundown: L.B. Foster (NASDAQ:FSTR) Vs Other General Industrial Machinery Stocks (StockStory)
May-19-25 09:07AM	FSTR Q1 Earnings Call: Rail Weakness Drives Revenue Miss, Management Maintains Bullish Full-Year Outlook (StockStory)
May-06-25 10:00AM	Compared to Estimates, L.B. Foster (FSTR) Q1 Earnings: A Look at Key Metrics (Zacks)
09:20AM	L.B. Foster (FSTR) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:16AM	L.B. Foster: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	L.B. Foster Announces 2025 First Quarter Results; Maintaining 2025 Full Year Financial Guidance Driven by Strong Order Book Development (GlobeNewswire)
May-05-25 10:18AM	L.B. Foster Co (FSTR) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-02-25 03:19PM	Are Options Traders Betting on a Big Move in L.B. Foster (FSTR) Stock? (Zacks)
May-01-25 05:35PM	United States Steel (X) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-29-25 05:40PM	L.B. Foster Company: Shares Are Finally Worth Considering (Rating Upgrade) (Seeking Alpha)
01:01PM	L.B. Foster Company to Report First Quarter 2025 Results on May 6, 2025 (GlobeNewswire)
09:05AM	1 Volatile Stock to Consider Right Now and 2 to Question (StockStory)
Apr-28-25 05:40PM	Nucor (NUE) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-27-25 05:45AM	L.B. Foster Company (FSTR): Among The Best Railroad Stocks To Buy According To Billionaires (Insider Monkey)
05:45AM	L.B. Foster Company (FSTR): Among The Best Railroad Stocks To Buy According To Billionaires (ready for edit 2) (Insider Monkey)
Apr-25-25 09:14AM	2 Industrials Stocks for Long-Term Investors and 1 to Approach with Caution (StockStory)
Apr-17-25 09:01AM	3 of Wall Street's Favorite Stocks Showing Warning Signs (StockStory)
Apr-10-25 08:55AM	ArcelorMittal (MT) Moves 14.9% Higher: Will This Strength Last? (Zacks)
05:05AM	3 Reasons to Avoid FSTR and 1 Stock to Buy Instead (StockStory)
Mar-24-25 05:02AM	General Industrial Machinery Stocks Q4 Teardown: L.B. Foster (NASDAQ:FSTR) Vs The Rest (StockStory)
Mar-21-25 10:07AM	Do Options Traders Know Something About L.B. Foster (FSTR) Stock We Don't? (Zacks)
Mar-18-25 09:00AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-14-25 11:46AM	Is L.B. Foster Company (FSTR) The Best Railroad Stock To Buy Now? (Insider Monkey)
Mar-13-25 01:00PM	L.B. Foster Company to Present Virtually at Sidoti Small Cap Conference on March 20, 2025 (GlobeNewswire)
Mar-05-25 04:11AM	Q4 2024 L B Foster Co Earnings Call (Thomson Reuters StreetEvents)
02:08AM	L.B. Foster Co (FSTR) Q4 2024 Earnings Call Highlights: Strong Profitability Amid Market Challenges (GuruFocus.com)
Mar-04-25 09:15AM	L.B. Foster (FSTR) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -12.31%
08:20AM	L.B. Foster: Q4 Earnings Snapshot (Associated Press Finance)
08:05AM	L.B. Foster (NASDAQ:FSTR) Misses Q4 Sales Targets, But Stock Soars 5.2% (StockStory)
08:00AM	L.B. Foster Company Ends 2024 with Continuing Profitability Growth and Strong Cash Flow; Approves New, 3-Year $40 million Stock Repurchase Plan (GlobeNewswire)
Mar-03-25 08:05AM	Earnings To Watch: L.B. Foster (FSTR) Reports Q4 Results Tomorrow (StockStory) -6.16%
07:18AM	L.B. Foster Co (FSTR) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-25-25 04:27PM	L.B. Foster Company to Report Fourth Quarter and Full Year 2024 Operating Results on March 4, 2025 (GlobeNewswire)
Jan-14-25 04:05AM	Q3 Earnings Highlights: John Bean (NYSE:JBT) Vs The Rest Of The General Industrial Machinery Stocks (StockStory)
Dec-05-24 01:00PM	L.B. Foster Company to Present at Singular Research's Best of the Uncovereds Conference on December 12, 2024 (GlobeNewswire)
Dec-04-24 01:32AM	General Industrial Machinery Stocks Q3 In Review: L.B. Foster (NASDAQ:FSTR) Vs Peers (StockStory)
Nov-09-24 06:00AM	L.B. Foster Co (FSTR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-07-24 09:20AM	L.B. Foster (FSTR) Tops Q3 Earnings Estimates (Zacks)
08:33AM	L.B. Foster (NASDAQ:FSTR) Misses Q3 Sales Targets (StockStory)
08:21AM	L.B. Foster: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	L.B. Foster Company Continues to Deliver on its Strategy Reporting Strong Growth in Profitability and Cash Generation in Third Quarter Results (GlobeNewswire)
Nov-06-24 07:44AM	L.B. Foster Co (FSTR) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com) +8.10%
02:07AM	L.B. Foster (FSTR) Q3 Earnings: What To Expect (StockStory)
Oct-31-24 12:00PM	L.B. Foster Company to Report Third Quarter 2024 Results on November 7, 2024 (GlobeNewswire)
Sep-20-24 04:44AM	General Industrial Machinery Stocks Q2 In Review: L.B. Foster (NASDAQ:FSTR) Vs Peers (StockStory)
Sep-04-24 01:00PM	L.B. Foster Company to Present Virtually at Singular Research Autumn Equinox 2024 Webinar on September 11, 2024 (GlobeNewswire)
Aug-13-24 09:30AM	Sidoti Events, LLC's Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-08-24 09:30AM	L.B. Foster Company to Present Virtually at Sidoti Micro Cap Investor Conference on August 14, 2024 and at Three Part Advisors' Midwest IDEAS Investor Conference on August 29, 2024 in Chicago, IL (GlobeNewswire) +12.00%
Aug-06-24 12:45PM	Why L.B. Foster (FSTR) Shares Are Trading Lower Today (StockStory) -19.72%
09:15AM	L.B. Foster (FSTR) Q2 Earnings Lag Estimates (Zacks)

L.B. Foster Co. engages in providing products and services for the rail industry and solutions to support infrastructure projects. It operates through the following segments: Rail Technologies & Services, Precast and Steel Products & Measurement. The Rail Technologies & Services segment consists of manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies. The Precast Concrete Products segment involves manufacturing, distribution, and service businesses that provide products and services for the transportation, energy, and general infrastructure markets in North America. The Steel Products and Measurement segment designs, manufactures, and supplies steel bridge products to contractors performing installation and repair work to North American transportation infrastructure network. The company was founded by Lee B. Foster in 1902 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
English Aron R.	10% Owner	Nov 28 '25	Sale	27.09	1,307	35,401	1,264,497	Dec 02 05:17 PM
English Aron R.	10% Owner	Dec 01 '25	Sale	26.82	101	2,708	1,264,396	Dec 02 05:17 PM
English Aron R.	10% Owner	Nov 24 '25	Sale	26.84	27,003	724,644	1,267,529	Nov 25 08:02 PM
English Aron R.	10% Owner	Nov 21 '25	Sale	27.03	3,412	92,222	1,294,532	Nov 25 08:02 PM
English Aron R.	10% Owner	Nov 25 '25	Sale	26.94	1,725	46,467	1,265,804	Nov 25 08:02 PM
English Aron R.	10% Owner	Nov 14 '25	Sale	27.00	2,247	60,669	1,298,344	Nov 18 04:43 PM
English Aron R.	10% Owner	Nov 17 '25	Sale	27.00	400	10,800	1,297,944	Nov 18 04:43 PM
English Aron R.	10% Owner	Nov 11 '25	Sale	27.94	7,562	211,255	1,305,559	Nov 13 06:50 PM
English Aron R.	10% Owner	Nov 12 '25	Sale	27.06	3,368	91,153	1,302,191	Nov 13 06:50 PM
English Aron R.	10% Owner	Nov 13 '25	Sale	27.00	1,600	43,203	1,300,591	Nov 13 06:50 PM
Kelly Brian H	EVP and Sr. Advisor to the CEO	Nov 07 '25	Sale	27.15	10,000	271,500	79,027	Nov 10 05:05 PM
Brian Kelly	Officer	Nov 07 '25	Proposed Sale	27.10	10,000	271,000		Nov 07 07:13 PM

LFCR Lifecore Biomedical Inc daily Stock Chart

Peers: ISRG ABT SYK MDT ZBH BSX BAX EW PEN TFX

| Held by: VTI IWM VXF IWO VTWO IWC IWN EES VTWG RSSL

Index	RUT	P/E	-	EPS (ttm)	-1.30	Insider Own	8.46%	Shs Outstand	37.47M	Perf Week	-3.42%
Market Cap	285.87M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	34.30M	Perf Month	12.70%
Enterprise Value	452.04M	PEG	-	EPS next Q	-	Inst Own	70.38%	Short Float	8.06%	Perf Quarter	4.66%
Income	-44.36M	P/S	2.22	EPS this Y	-	Inst Trans	-0.21%	Short Ratio	15.45	Perf Half Y	11.39%
Sales	128.87M	P/B	-	EPS next Y	-	ROA	-15.09%	Short Interest	2.76M	Perf YTD	2.69%
Book/sh	-0.28	P/C	15.16	EPS next 5Y	-	ROE	-76.41%	52W High	8.85 -13.79%	Perf Year	2.14%
Cash/sh	0.50	P/FCF	-	EPS past 3/5Y	31.55% 0.55%	ROIC	-25.64%	52W Low	4.76 60.29%	Perf 3Y	-10.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.02% -26.24%	Gross Margin	31.27%	Volatility	3.45% 5.04%	Perf 5Y	-26.28%
Dividend TTM	-	EV/Sales	3.51	EPS Y/Y TTM	-430.88%	Oper. Margin	-9.35%	ATR (14)	0.32	Perf 10Y	-39.40%
Dividend Ex-Date	-	Quick Ratio	1.67	Sales Y/Y TTM	0.47%	Profit Margin	-34.42%	RSI (14)	52.56	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	2.80	EPS Q/Q	44.52%	SMA20	-0.70%	Beta	0.60	Target Price	8.75
Payout	-	Debt/Eq	3.74	Sales Q/Q	25.92%	SMA50	6.32%	Rel Volume	0.59	Prev Close	7.77
Employees	406	LT Debt/Eq	3.70	Earnings	Nov 06 AMC	SMA200	8.30%	Avg Volume	178.97K	Price	7.63
IPO	Feb 15, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.44% 18.47%	Trades		Volume	104,775	Change	-1.80%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-04-25	Initiated	KeyBanc Capital Markets	Sector Weight
May-21-25	Initiated	William Blair	Outperform
Sep-05-24	Initiated	Craig Hallum	Buy	$8
Aug-28-24	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-20-23	Downgrade	Stephens	Overweight → Equal-Weight	$11 → $2

Nov-11-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.17% +6.20%
Nov-10-25 08:41AM	An Analysis of LifeCore's (LFCR) Growth Potential (Insider Monkey) +6.42%
Nov-07-25 12:00AM	Lifecore Biomedical Inc (LFCR) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Nov-06-25 05:40PM	Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates (Zacks)
04:38PM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update (GlobeNewswire)
Nov-04-25 08:40AM	Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates (Zacks)
Oct-30-25 04:05PM	Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 (GlobeNewswire)
08:13AM	Here's Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 (Insider Monkey)
Oct-29-25 07:00AM	Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company (GlobeNewswire)
06:07AM	Lifecore and PolyPeptide link for US peptide manufacturing (Pharmaceutical Technology)
Oct-28-25 07:00AM	Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market (GlobeNewswire)
Oct-13-25 07:00AM	Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events (GlobeNewswire)
Sep-26-25 10:00AM	Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Sep-23-25 04:30PM	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -10.70%
09:09AM	Loading…
Sep-12-25 09:09AM	Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? (Zacks)
Sep-04-25 04:05PM	Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference (GlobeNewswire) -5.16%
Sep-02-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-19-25 09:36AM	Does LifeCore (LFCR) Have a High Expected Value? (Insider Monkey)
Aug-07-25 07:35PM	Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.70%
06:35PM	Lifecore Biomedical: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-05-25 08:20AM	ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-31-25 04:05PM	Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-24-25 07:40AM	Laughing Water Capital's View on Lifecore Biomedical Inc. (LFCR) (Insider Monkey)
Jul-17-25 04:05PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-17-25 07:00AM	Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer (GlobeNewswire)
Jun-12-25 07:00AM	Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale (GlobeNewswire)
May-27-25 07:00AM	Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer (GlobeNewswire)
Apr-24-25 11:30AM	Laughing Water Capital Top 5 Investments (Q1 2025) (Seeking Alpha)
09:30AM	Loading…
09:30AM	Laughing Water Capital Q1 2025 Letter (Seeking Alpha)
Apr-22-25 07:00AM	Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference (GlobeNewswire)
Apr-16-25 04:05PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-14-25 07:00AM	Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer (GlobeNewswire) +6.01%
Apr-05-25 12:10PM	China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz (TipRanks)
Apr-04-25 07:09AM	Q3 2025 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) -22.32%
03:01AM	Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-03-25 07:43PM	Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript (Seeking Alpha) -5.42%
05:20PM	Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:17PM	Lifecore Biomedical: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-31-25 05:15PM	Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-27-25 04:05PM	Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025 (GlobeNewswire)
Mar-17-25 07:00AM	Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome (GlobeNewswire)
Mar-07-25 09:55AM	Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now? (Insider Monkey)
07:20AM	Greenhaven Road Capitals Updates on Lifecore Biomedical (LFCR) (Insider Monkey)
Feb-26-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences (GlobeNewswire)
Feb-03-25 07:00AM	Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference (GlobeNewswire)
Jan-22-25 09:36AM	Here are Laughing Water Capitals Updates on Lifecore Biomedical (LFCR) (Insider Monkey)
Jan-17-25 05:24PM	Lifecore Biomedical Announces Special Stockholder Meeting (GlobeNewswire)
Jan-07-25 09:00AM	Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million (GlobeNewswire) -13.97%
Jan-06-25 04:05PM	Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -9.84%
Jan-03-25 09:44AM	Q2 2025 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) +14.41%
02:00AM	Lifecore Biomedical Inc (LFCR) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising ... (GuruFocus.com)
Jan-02-25 05:15PM	Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -10.36%
04:15PM	Lifecore Biomedical: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Jan-01-25 07:01AM	Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 2025 Result (GuruFocus.com)
Dec-29-24 05:00AM	What to Expect in the Markets This Week (Investopedia)
Dec-19-24 04:05PM	Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 (GlobeNewswire)
07:00AM	Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment (GlobeNewswire)
Dec-12-24 10:03AM	Heres Why Arquitos Capital Management Largely Exited Lifecore (LFCR) (Insider Monkey)
Nov-26-24 04:05PM	Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO (GlobeNewswire)
Nov-21-24 04:17PM	Lifecore Biomedical Hosts Virtual Investor Day (GlobeNewswire) -6.68%
Nov-15-24 08:44AM	Heres Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) (Insider Monkey)
Nov-12-24 04:05PM	Lifecore Biomedical to Present at Stephens Annual Investment Conference (GlobeNewswire) +7.34%
Nov-07-24 07:00AM	Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 (GlobeNewswire)
Nov-04-24 07:00AM	Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations (GlobeNewswire)
Oct-17-24 07:30AM	Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer (GlobeNewswire) +9.76%
Oct-07-24 09:12PM	Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc (GuruFocus.com) -5.39% -5.50%
01:00AM	Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
Oct-04-24 07:52AM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +14.35%
07:30AM	Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
07:20AM	Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock (GlobeNewswire)
Oct-03-24 04:05PM	Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 (GlobeNewswire) -5.33%
Oct-01-24 07:00AM	Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology (GlobeNewswire)
Sep-25-24 04:05PM	Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events (GlobeNewswire) -5.01%
Sep-19-24 07:00AM	Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational (GlobeNewswire) +8.08%
Sep-12-24 04:05PM	Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference (GlobeNewswire) +5.57%
07:00AM	Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Sep-10-24 07:00AM	Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources (GlobeNewswire)
Sep-06-24 04:05PM	Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-05-24 04:05PM	Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference (GlobeNewswire) +8.53%
Aug-29-24 07:00AM	Lifecore Biomedical Announces Chief Financial Officer Transition (GlobeNewswire)
Aug-27-24 11:59PM	Q4 2024 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) -25.24% -16.24%
Aug-26-24 05:23PM	Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update (GlobeNewswire) +5.67%
Aug-09-24 05:51PM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +8.38%
Jul-26-24 03:30AM	Laughing Water Capital is Waiting for an Investor Update from Lifecore Biomedical (LFCR) (Insider Monkey)
Jul-11-24 02:51AM	Cove Street Capital Sold its Holding in Lifecore Biomedical (LFCR) (Insider Monkey) +5.71%
Jul-01-24 08:00AM	Lifecore Biomedical Announces Cooperation Agreement with 22NW (GlobeNewswire) -7.99%
May-22-24 04:16PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-16-24 04:45PM	Lifecore Biomedical Completes Incremental Liquidity Initiatives (GlobeNewswire)
May-08-24 12:26PM	Hidden Gems: Unveiling the 10 Stocks on Hedge Funds' Radar (Insider Monkey)
May-03-24 03:31AM	Do You Believe in the Upside Trajectory of Avid Bioservices (CDMO)? (Insider Monkey)
02:44AM	Here's Why Laughing Water Capital Invested in Lifecore Biomedical (LFCR) (Insider Monkey)
Apr-22-24 10:59AM	What Made White Falcon Hold Lifecore Biomedical (LFCR)? (Insider Monkey) -5.98%
10:29AM	Endava plc (DAVA) Was Down 40% in Q1 (Insider Monkey)
Apr-19-24 04:30PM	Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report (GlobeNewswire) +5.94%
Apr-11-24 02:21AM	Do You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)? (Insider Monkey) +5.47%
Apr-01-24 08:00AM	Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress (GlobeNewswire) +9.04%

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
English Aron R.	10% Owner	May 27 '25	Sale	6.50	1,139,504	7,411,562	414,599	May 28 08:06 PM
English Aron R.	10% Owner	May 28 '25	Sale	7.12	150,419	1,071,555	264,180	May 28 08:06 PM
English Aron R.	10% Owner	May 23 '25	Sale	6.75	96,137	649,386	1,554,103	May 28 08:06 PM
English Aron R.	10% Owner	May 13 '25	Sale	7.00	12,334	86,353	1,650,240	May 16 11:28 AM
English Aron R.	10% Owner	May 12 '25	Sale	7.03	45,698	321,426	1,662,574	May 12 06:58 PM
English Aron R.	10% Owner	May 08 '25	Sale	7.00	5,098	35,693	1,708,972	May 12 06:58 PM
English Aron R.	10% Owner	May 09 '25	Sale	7.00	700	4,900	1,708,272	May 12 06:58 PM
English Aron R.	10% Owner	May 05 '25	Sale	7.08	24,543	173,831	1,730,618	May 07 09:09 PM
English Aron R.	10% Owner	May 07 '25	Sale	7.01	15,847	111,099	1,714,070	May 07 09:09 PM
English Aron R.	10% Owner	May 06 '25	Sale	7.05	701	4,940	1,729,917	May 07 09:09 PM
Josephs Paul	Chief Executive Officer	Jan 08 '25	Buy	5.74	17,000	97,580	559,717	Jan 08 04:10 PM

Open in Screener

CULP

Culp Inc

Dec 05 • 04:00PM ET

3.85

+0.02 0.52 %

Consumer Cyclical • Textile Manufacturing • USA • NYSE

Peers: SGI LEG WSM LZB VFC HNI BSET CRD-A SNBR HOFT

| Held by: VTI VXF DFAT IWC DFAS DFAC DFUV DFSU DFUS DFSV

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	11.48%	Shs Outstand	12.61M	Perf Week	-3.51%
Market Cap	48.53M	Forward P/E	-	EPS next Y	0.00	Insider Trans	1.91%	Shs Float	11.16M	Perf Month	-2.53%
Enterprise Value	58.39M	PEG	-	EPS next Q	-0.18	Inst Own	61.69%	Short Float	0.23%	Perf Quarter	-10.26%
Income	-12.07M	P/S	0.23	EPS this Y	66.01%	Inst Trans	-0.06%	Short Ratio	1.14	Perf Half Y	-6.33%
Sales	207.39M	P/B	0.84	EPS next Y	100.00%	ROA	-9.45%	Short Interest	0.03M	Perf YTD	-34.41%
Book/sh	4.57	P/C	3.89	EPS next 5Y	-	ROE	-19.05%	52W High	5.94 -35.19%	Perf Year	-23.61%
Cash/sh	0.99	P/FCF	-	EPS past 3/5Y	-79.82% 6.75%	ROIC	-18.11%	52W Low	3.42 12.57%	Perf 3Y	-24.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-10.24% -3.60%	Gross Margin	13.85%	Volatility	2.84% 3.26%	Perf 5Y	-73.11%
Dividend TTM	-	EV/Sales	0.28	EPS Y/Y TTM	32.31%	Oper. Margin	-3.28%	ATR (14)	0.13	Perf 10Y	-86.17%
Dividend Ex-Date	Apr 08, 2022	Quick Ratio	0.81	Sales Y/Y TTM	-7.91%	Profit Margin	-5.82%	RSI (14)	42.96	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.86	EPS Q/Q	96.84%	SMA20	-1.10%	Beta	1.04	Target Price	8.00
Payout	-	Debt/Eq	0.39	Sales Q/Q	-10.34%	SMA50	-5.65%	Rel Volume	0.86	Prev Close	3.83
Employees	829	LT Debt/Eq	0.16	Earnings	Sep 10 AMC	SMA200	-10.12%	Avg Volume	22.71K	Price	3.85
IPO	Aug 30, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	83.33% -11.84%	Trades		Volume	19,492	Change	0.52%

Date	Action	Analyst	Rating Change	Price Target Change
May-29-20	Upgrade	Stifel	Hold → Buy	$8 → $13
Feb-19-20	Downgrade	Stifel	Buy → Hold	$20 → $11
Mar-01-19	Upgrade	Raymond James	Mkt Perform → Outperform	$22

Dec-05-25 02:30PM	Culp, Inc. to Webcast Second Quarter Fiscal 2026 Conference Call (Business Wire)
Nov-20-25 08:40AM	Warner Music Group Corp. (WMG) Q4 Earnings Lag Estimates (Zacks)
Nov-18-25 05:25PM	Dolby Laboratories (DLB) Q4 Earnings and Revenues Beat Estimates (Zacks)
Sep-12-25 03:01AM	Culp Inc (CULP) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Improvements (GuruFocus.com)
Sep-10-25 05:45PM	Culp, Inc. (CULP) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:30PM	Loading…
04:30PM	Culp Announces First Quarter Fiscal 2026 Results (Business Wire)
09:18AM	Earnings To Watch: Culp Inc (CULP) Reports Q1 2026 Result (GuruFocus.com)
Sep-09-25 09:18AM	What To Expect From Culp Inc (CULP) Q1 2026 Earnings (GuruFocus.com) +6.06%
Sep-04-25 02:00PM	Culp, Inc. to Webcast First Quarter Fiscal 2026 Conference Call (Business Wire)
Aug-07-25 06:40PM	E.W. Scripps (SSP) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jun-27-25 03:01AM	Culp Inc (CULP) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Jun-25-25 04:15PM	Culp Announces Fourth Quarter and Full Year Fiscal 2025 Results, Completed Restructuring Provides Foundation for Improved Operating Performance in Fiscal 2026 (Business Wire)
09:19AM	Culp Inc (CULP) Q4 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jun-20-25 03:42PM	Culp, Inc. to Webcast Fourth Quarter and Fiscal 2025 Conference Call (Business Wire)
Jun-09-25 04:15PM	Culp Enters Into Multi-Year Agreement With Largest Shareholder (Business Wire) -5.60%
04:15PM	Loading…
May-12-25 04:15PM	Culp Completes Sale of Canada Manufacturing Facility (Business Wire)
Apr-24-25 09:35AM	Culp, Inc. Announces Strategic Transformation of Operating Model Following Completion of Restructuring Initiatives (Business Wire) +5.03%
Mar-07-25 02:01PM	Culp Inc (CULP) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Mar-05-25 04:20PM	Culp Elects New Member to Board of Directors (Business Wire) -12.35%
04:15PM	Culp Announces Results for Third Quarter Fiscal 2025, Highlighted by Continued Improvement in Mattress Fabrics Operating Performance and Execution on Restructuring Initiatives (Business Wire)
Feb-28-25 03:15PM	Culp, Inc. to Webcast Third Quarter Fiscal 2025 Conference Call (Business Wire)
Dec-06-24 05:16AM	Q2 2025 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
02:01AM	Culp Inc (CULP) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Dec-04-24 04:15PM	Culp Announces Results for Second Quarter Fiscal 2025, Highlighted by Sequential Improvement in Mattress Fabrics Performance, Along With Steady Restructuring Progress (Business Wire)
Nov-27-24 12:06PM	Culp, Inc. to Webcast Second Quarter Fiscal 2025 Conference Call (Business Wire)
Nov-04-24 09:55AM	Culp, Inc. (CULP): A Bull Case Theory (Insider Monkey)
Sep-06-24 01:20AM	Q1 2025 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Sep-04-24 04:15PM	Culp Announces Results for First Quarter Fiscal 2025, Highlighted by a 14.2% Sequential Increase in Sales and Stable Cash Position (Business Wire)
Aug-29-24 02:18PM	Culp, Inc. to Webcast First Quarter Fiscal 2025 Conference Call (Business Wire)
Jul-22-24 01:44PM	Culp Names Mary Beth Hunsberger as President of Culp Upholstery Fabrics (Business Wire)
08:02AM	Loading…
Jul-03-24 08:02AM	Culp, Inc. (NYSE:CULP) Q4 2024 Earnings Call Transcript (Insider Monkey) +7.32%
Jun-29-24 05:21AM	Q4 2024 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Jun-27-24 08:52PM	CULP Stock Earnings: Culp Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace)
05:25PM	Culp, Inc. (CULP) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for Fourth Quarter and Fiscal 2024, Provides Update on Restructuring Initiatives (Business Wire)
Jun-24-24 02:30PM	Culp, Inc. to Webcast Fourth Quarter and Fiscal 2024 Conference Call (Business Wire)
Jun-17-24 04:15PM	Alexander B. Jones from 22NW, LP to be Added to the Board and Nominated to Serve on Culp, Inc. Board of Directors at 2024 Annual Shareholders Meeting. (Business Wire)
May-01-24 04:10PM	Culp Announces Broad Restructuring Plan Primarily Focused on Mattress Fabrics Segment, Also Updates Financial Outlook for the Fourth Quarter of Fiscal 2024 (Business Wire)
Mar-08-24 09:19AM	Culp, Inc. (NYSE:CULP) Q3 2024 Earnings Call Transcript (Insider Monkey)
01:25AM	Q3 2024 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-24 12:38PM	Culp's (CULP) Q3 Earnings Miss Estimates, Revenues Beat (Zacks) +7.02%
Mar-06-24 05:30PM	Culp, Inc. (CULP) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for Third Quarter Fiscal 2024, With Continued Sequential and Year-Over-Year Operating Improvement (Business Wire)
Mar-05-24 01:02PM	Culp (CULP) to Report Q3 Earnings: Here's What to Expect (Zacks)
Mar-01-24 03:15PM	Culp, Inc. to Webcast Third Quarter Fiscal 2024 Conference Call (Business Wire)
Feb-14-24 02:41AM	Jim Simons Adds Culp Inc to Renaissance Technologies' Portfolio (GuruFocus.com)
Jan-10-24 11:00AM	Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024 (Business Wire)
Jan-08-24 04:15PM	Culp Announces Leadership Addition at Culp Upholstery Fabrics, Along With Planned Transition for Division President Boyd Chumbley (Business Wire)
Dec-06-23 08:29AM	Culp, Inc. (NYSE:CULP) Q2 2024 Earnings Call Transcript (Insider Monkey)
03:18AM	Q2 2024 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Dec-05-23 01:13PM	Culp's (CULP) Q2 Earnings & Revenues Beat Estimates, Stock Up (Zacks) +9.68%
Dec-04-23 05:25PM	Culp, Inc. (CULP) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for Second Quarter Fiscal 2024, With Continued Sequential and Strong Year-Over-Year Operating Improvement and a Solid Financial Position (Business Wire)
Dec-01-23 11:08AM	Culp (CULP) to Report Q2 Earnings: Here's What to Expect (Zacks)
Nov-27-23 03:15PM	Culp, Inc. to Webcast Second Quarter Fiscal 2024 Conference Call (Business Wire)
Sep-16-23 03:00AM	Insider Buying: President, Mattress Fabrics Thomas Bruno Acquires 2,924 Shares of Culp Inc (GuruFocus.com)
Sep-14-23 03:05PM	Insider Buying: Director Jonathan Kelly Acquires 2000 Shares of Culp Inc (GuruFocus.com)
Sep-01-23 08:53AM	Culp, Inc. (NYSE:CULP) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:41AM	Q1 2024 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-31-23 11:19AM	Culp's (CULP) Q1 Earnings Beat Estimates, Revenues Miss (Zacks)
07:49AM	High Point's Culp Inc. sees things slowly improving but reports another down quarter (American City Business Journals)
Aug-30-23 05:40PM	Culp, Inc. (CULP) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for First Quarter Fiscal 2024, With Better-than-Expected Operating Improvement and Continued Solid Financial Position (Business Wire)
Aug-28-23 11:11AM	Culp (CULP) to Report Strong Q1 Earnings: Factors to Note (Zacks)
Aug-25-23 03:15PM	Culp, Inc. to Webcast First Quarter Fiscal 2024 Conference Call (Business Wire)
Aug-03-23 01:05PM	Culp Announces 2023 Annual Meeting Date (Business Wire)
Jul-26-23 01:12PM	Daily Vickers Top Buyers & Sellers for 07/26/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Buyers & Sellers for 07/24/2023 (Argus Research)
Jul-17-23 07:44AM	3 Penny Stocks That Will Skyrocket Before 2025 (InvestorPlace)
Jul-12-23 07:22AM	Daily Vickers Top Buyers & Sellers for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Buyers & Sellers for 07/11/2023 (Argus Research)
Jul-01-23 07:59AM	Culp, Inc. (NYSE:CULP) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jun-30-23 03:32AM	Q4 2023 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Jun-28-23 05:35PM	Culp, Inc. (CULP) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for Fourth Quarter and Fiscal 2023, Ends Year With Quarterly Sales and Operating Improvement and Higher Cash Position (Business Wire)
Jun-27-23 11:36AM	Culp (NYSE:CULP) Is In A Strong Position To Grow Its Business (Simply Wall St.)
Jun-23-23 11:00AM	Culp, Inc. to Webcast Fourth Quarter and Fiscal 2023 Conference Call (Business Wire)
May-31-23 10:25AM	Several Insiders Invested In Culp Flagging Positive News \ (Simply Wall St.)
May-04-23 06:59AM	Why Culp, Inc. (NYSE:CULP) Could Be Worth Watching (Simply Wall St.)
Apr-06-23 11:00AM	Culp, Inc. to Participate in Water Tower Research Fireside Chat Series (Business Wire)
Mar-27-23 02:21PM	Investors in Culp (NYSE:CULP) have unfortunately lost 80% over the last five years (Simply Wall St.)
Mar-11-23 07:05AM	Culp Third Quarter 2023 Earnings: Misses Expectations (Simply Wall St.)
Mar-05-23 07:14AM	Culp, Inc. (NYSE:CULP) Shares Could Be 30% Above Their Intrinsic Value Estimate (Simply Wall St.)
Mar-03-23 01:29AM	Q3 2023 Culp Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-01-23 07:35PM	Culp, Inc. (CULP) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for Third Quarter Fiscal 2023 (Business Wire)
Feb-24-23 03:15PM	Culp, Inc. to Webcast Third Quarter Fiscal 2023 Conference Call (Business Wire)
Jan-18-23 09:33AM	We're Hopeful That Culp (NYSE:CULP) Will Use Its Cash Wisely (Simply Wall St.)
Dec-22-22 08:45AM	Great news for Culp, Inc. (NYSE:CULP): Insiders acquired stock in large numbers last year (Simply Wall St.)
Dec-14-22 12:15AM	Culp, Inc. (NYSE:CULP) Q2 2023 Earnings Call Transcript (Insider Monkey)
Dec-08-22 07:49AM	Culp has rough quarter, focuses on efficiency and hospitality bright spot (American City Business Journals)
Dec-07-22 05:35PM	Culp, Inc. (CULP) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Culp Announces Results for Second Quarter Fiscal 2023, Including Inventory Impairments and Markdowns of Inventory and Improved Cash Position (Business Wire)
Nov-30-22 10:00AM	Earnings Preview: Culp, Inc. (CULP) Q2 Earnings Expected to Decline (Zacks)
Nov-29-22 02:00PM	Culp, Inc. to Webcast Second Quarter Fiscal 2023 Conference Call (Business Wire)
Nov-25-22 05:26AM	Should You Investigate Culp, Inc. (NYSE:CULP) At US$5.31? (Simply Wall St.)
Nov-23-22 03:00PM	Culp issues lowered expectations in face of macro-economic and consumer trends (American City Business Journals)
Nov-22-22 04:15PM	Culp Announces Revised Expectations, Including Impairment and Markdowns of Inventory, and Improved Cash Position for Second Quarter Fiscal 2023 (Business Wire)
Nov-09-22 08:35AM	Rogers Communication (RCI) Lags Q3 Earnings Estimates (Zacks)
Oct-10-22 12:23PM	Culp (NYSE:CULP) investors are sitting on a loss of 85% if they invested five years ago (Simply Wall St.)

Culp, Inc. engages in the design, manufacture, and trade of mattresses and upholstery products. It operates through the Mattress Fabrics and Upholstery Fabrics segments. The Mattress Fabrics segment markets and sells covers and beddings under the Culp Home Fashions brand. The Upholstery Fabrics segment produces and supplies fabrics for residential and commercial manufacturers. The company was founded by Robert G. Culp, Jr. and Robert G. Culp, III in 1972 and is headquartered in High Point, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JACKSON FRED A	Director	Sep 24 '25	Option Exercise	0.00	10,033	0	91,073	Sep 25 06:07 PM
Gatling Kimberly Bullock	Director	Sep 24 '25	Option Exercise	0.00	9,197	0	47,590	Sep 25 05:30 PM
Jones Alexander B	Director	Sep 24 '25	Option Exercise	0.00	9,197	0	9,722	Sep 25 04:49 PM
DECKER SHARON A	Former Director	Sep 24 '25	Option Exercise	0.00	9,197	0	54,580	Sep 25 11:58 AM
Baugh John Allen	Former Director	Sep 24 '25	Option Exercise	0.00	9,197	0	56,275	Sep 25 11:03 AM
CULP ROBERT GEORGE IV	President & CEO	Sep 22 '25	Buy	4.42	7,428	32,832	111,458	Sep 23 06:09 PM
Gatling Kimberly Bullock	Director	Sep 22 '25	Buy	4.30	2,347	10,091	38,393	Sep 23 05:11 PM
Bruno Thomas	Chief Commercial Officer	Sep 22 '25	Buy	4.35	5,372	23,372	80,000	Sep 23 04:50 PM
Bruno Thomas	Chief Commercial Officer	Sep 06 '25	Option Exercise	0.00	12,557	0	78,628	Sep 09 01:25 PM
Bruno Thomas	Chief Commercial Officer	Jul 11 '25	Option Exercise	0.00	9,197	0	65,675	Jul 15 11:53 AM
Bowling Kenneth R	EVP & CFO	Jul 11 '25	Option Exercise	0.00	11,315	0	43,911	Jul 15 11:35 AM
Huffman Teresa Atkins	SVP & CHRO	Jul 11 '25	Option Exercise	0.00	5,242	0	12,209	Jul 15 10:49 AM
Chandler Ronald S	VP & Corporate Controller	Jul 11 '25	Option Exercise	0.00	1,500	0	3,041	Jul 15 08:54 AM
CULP ROBERT GEORGE IV	President & CEO	Jul 11 '25	Option Exercise	0.00	13,935	0	295,710	Jul 14 07:32 PM
CULP ROBERT GEORGE IV	President & CEO	Jul 01 '25	Buy	4.15	12,000	49,800	104,030	Jul 03 09:25 AM
Kelly Jonathan Lee	Former Director	Mar 24 '25	Buy	5.40	700	3,782	49,521	Mar 25 04:11 PM
English Aron R.	10% Owner	Mar 18 '25	Buy	5.35	104,738	560,348	1,839,061	Mar 20 05:31 PM
English Aron R.	10% Owner	Mar 19 '25	Buy	5.60	20,000	111,954	1,859,061	Mar 20 05:31 PM
Kelly Jonathan Lee	Former Director	Mar 18 '25	Buy	5.33	250	1,332	48,821	Mar 20 08:46 AM
English Aron R.	10% Owner	Mar 13 '25	Buy	5.07	9,793	49,691	1,721,097	Mar 17 09:02 PM
English Aron R.	10% Owner	Mar 14 '25	Buy	5.08	9,006	45,744	1,730,103	Mar 17 09:02 PM
English Aron R.	10% Owner	Mar 17 '25	Buy	5.17	4,220	21,814	1,734,323	Mar 17 09:02 PM
English Aron R.	10% Owner	Mar 11 '25	Buy	5.00	66,663	333,128	1,705,227	Mar 12 06:59 PM
English Aron R.	10% Owner	Mar 10 '25	Buy	4.65	13,849	64,338	1,638,564	Mar 12 06:59 PM
English Aron R.	10% Owner	Mar 12 '25	Buy	5.05	6,077	30,697	1,711,304	Mar 12 06:59 PM
CULP ROBERT GEORGE IV	President & CEO	Mar 10 '25	Buy	4.94	14,001	69,165	92,030	Mar 12 11:22 AM
Gatling Kimberly Bullock	Director	Dec 30 '24	Buy	5.83	2,090	12,181	36,046	Jan 02 11:18 AM
English Aron R.	10% Owner	Dec 19 '24	Buy	5.25	7,634	40,078	1,620,151	Dec 20 08:06 PM
English Aron R.	10% Owner	Dec 20 '24	Buy	5.23	4,564	23,868	1,624,715	Dec 20 08:06 PM
English Aron R.	10% Owner	Dec 18 '24	Buy	5.25	1,246	6,540	1,612,517	Dec 20 08:06 PM
Hunsberger Mary Elizabeth	President, Upholstery Fabrics	Dec 16 '24	Buy	5.55	5,000	27,750	15,000	Dec 18 01:36 PM
CULP ROBERT GEORGE IV	President and CEO	Dec 10 '24	Buy	5.42	8,508	46,113	78,029	Dec 12 10:17 AM
English Aron R.	10% Owner	Dec 10 '24	Buy	5.05	11,794	59,617	1,608,971	Dec 11 05:37 PM
English Aron R.	10% Owner	Dec 09 '24	Buy	4.96	2,787	13,815	1,597,177	Dec 11 05:37 PM
English Aron R.	10% Owner	Dec 11 '24	Buy	5.23	2,300	12,018	1,611,271	Dec 11 05:37 PM
Baugh John Allen	Director	Dec 09 '24	Buy	4.95	5,000	24,750	47,078	Dec 10 01:16 PM

Open in Screener

ANEB

Anebulo Pharmaceuticals Inc

Dec 05 • 04:00PM ET

2.26

-0.11 -4.64 %

Healthcare • Biotechnology • USA • NASD

ANEB Anebulo Pharmaceuticals Inc daily Stock Chart

Peers: AXSM BTAI BHVN INVA CYTK EOLS GERN EBS ELDN

| Held by: VXF VTI IWC

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	40.54%	Shs Outstand	41.08M	Perf Week	-3.42%
Market Cap	92.85M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	24.43M	Perf Month	-11.02%
Enterprise Value	82.50M	PEG	-	EPS next Q	-	Inst Own	54.08%	Short Float	0.48%	Perf Quarter	2.73%
Income	-8.44M	P/S	-	EPS this Y	-	Inst Trans	-11.94%	Short Ratio	2.26	Perf Half Y	109.26%
Sales	0.00M	P/B	9.54	EPS next Y	-	ROA	-128.22%	Short Interest	0.12M	Perf YTD	34.52%
Book/sh	0.24	P/C	8.97	EPS next 5Y	-	ROE	-145.11%	52W High	3.42 -33.92%	Perf Year	45.81%
Cash/sh	0.25	P/FCF	-	EPS past 3/5Y	4.97% -102.33%	ROIC	-86.70%	52W Low	0.80 182.46%	Perf 3Y	-23.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.31% 4.18%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	23.10%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.93	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.86	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.93	EPS Q/Q	38.16%	SMA20	-3.71%	Beta	-0.87	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-7.99%	Rel Volume	0.15	Prev Close	2.37
Employees	3	LT Debt/Eq	0.00	Earnings	Nov 13 AMC	SMA200	20.82%	Avg Volume	51.63K	Price	2.26
IPO	May 07, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	7,739	Change	-4.64%

Nov-13-25 04:05PM	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates (Business Wire)
Sep-29-25 04:05PM	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates (Business Wire)
Sep-26-25 05:24AM	Anebulo begins Phase I trial of IV cannabis antidote (Clinical Trials Arena)
Sep-25-25 07:30AM	Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity (Business Wire)
Sep-12-25 07:30AM	Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives (Business Wire) +17.91%
10:51AM	Loading…
Jul-25-25 10:51AM	Cannabis Use Disorder (CUD) Pipeline Market Research Report 2025 Featuring Aelis Farma, Anebulo Pharmaceuticals, and Indivior (GlobeNewswire)
Jul-23-25 08:00AM	Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock (Business Wire) +81.97%
May-13-25 04:05PM	Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates (Business Wire)
Feb-14-25 04:05PM	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates (Business Wire) +9.77%
Dec-24-24 09:25AM	Anebulo Pharmaceuticals collaborates with FDA to advance selonabant (TipRanks) +29.60%
Dec-23-24 09:15AM	Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise (Business Wire) +26.26%
Nov-13-24 04:05PM	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates (Business Wire) -6.06%
Sep-25-24 04:05PM	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates (Business Wire) -11.48% +5.95%
Jul-22-24 07:00AM	Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects (Business Wire) +9.09%
Jul-01-24 08:00AM	Lifecore Biomedical Announces Cooperation Agreement with 22NW (GlobeNewswire)
09:55PM	Loading…
May-15-24 09:55PM	ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024 (InvestorPlace) -6.36%
01:05PM	Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates (Business Wire)
Feb-13-24 04:05PM	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates (Business Wire) +5.43%
Nov-14-23 04:05PM	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates (Business Wire) +5.19%
Oct-19-23 09:40AM	Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year? (Zacks) +13.67%
Oct-06-23 04:06PM	Anebulo Pharmaceuticals Announces New CEO (Business Wire)
04:06PM	Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors (Business Wire)
Oct-03-23 09:40AM	Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? (Zacks)
Sep-21-23 10:06AM	Enphase Energy upgraded, Brighthouse downgraded: Wall Street's top analyst calls (The Fly)
Sep-20-23 04:29PM	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates (Business Wire)
Aug-30-23 08:00AM	Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences (Business Wire) +6.92%
Aug-22-23 09:37AM	Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001 (Zacks) -5.83%
Aug-21-23 08:00AM	Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension (Business Wire) +10.36%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Jun-12-23 09:40AM	Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year? (Zacks) -5.66%
08:33AM	Loading…
May-30-23 08:33AM	We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully (Simply Wall St.)
May-24-23 09:40AM	Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year? (Zacks)
May-19-23 09:35AM	Down -26.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Anebulo Pharmaceuticals, Inc. (ANEB) (Zacks)
May-11-23 08:00AM	Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates (PR Newswire)
Mar-28-23 08:00AM	Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication (PR Newswire)
Mar-08-23 08:00AM	Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions (PR Newswire) -6.33%
Feb-14-23 09:30AM	Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences (ACCESSWIRE)
Feb-10-23 08:38AM	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates (Business Wire)
Jan-09-23 08:00AM	Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication (Business Wire)
Dec-21-22 05:42AM	Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth (Simply Wall St.) +15.52%
Nov-10-22 08:00AM	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates (Business Wire)
Nov-01-22 04:00PM	Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors (Business Wire) +20.33% -5.52%
Sep-26-22 08:56AM	Lower Doses Of Anebulo's ANEB-001 Reduces Negative Effects Of Higher Doses Of THC (Benzinga)
07:00AM	Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication (Business Wire)
07:00AM	Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing (Business Wire)
Sep-20-22 08:00AM	Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022 (Business Wire) -5.88%
Sep-09-22 08:00AM	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress (Business Wire)
Aug-23-22 05:00PM	Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 (Business Wire) -7.78% +6.37%
Aug-16-22 03:00PM	Sidoti's August Micro-Cap Virtual Conference (ACCESSWIRE)
Jul-14-22 06:23AM	We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely (Simply Wall St.) -22.73%
Jul-05-22 07:57AM	Anebulo's ANEB-001 Reduces Cannabis Intoxication In Healthy Participants (Benzinga)
06:00AM	Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication (Business Wire)
Jun-23-22 04:00PM	Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022 (Business Wire) +24.41% +17.97%
May-24-22 04:00PM	Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer (Business Wire)
May-11-22 09:00AM	Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates (Business Wire) -10.29%
Apr-01-22 07:00AM	Anebulo Pharmaceuticals Doses More Than Half of the Subjects in Part A of a Phase 2 Clinical Trial and Provides Guidance on IND Submission (Business Wire)
Feb-11-22 08:00AM	Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2022 Financial Results and Recent Updates (Business Wire)
Feb-04-22 04:30AM	We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely (Simply Wall St.) -5.28%
Jan-06-22 07:00AM	Anebulo Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)
07:00AM	Anebulo Pharmaceuticals Appoints Scott L. Anderson as Head of Investor Relations and Public Relations (Business Wire)
Jan-04-22 07:00AM	Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director (Business Wire)
Jan-03-22 07:00AM	Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication (Business Wire)
Nov-12-21 08:00AM	Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update (Business Wire)
Oct-13-21 08:00AM	Anebulo Pharmaceuticals Announces Issuance of U.S. Patent Covering Use of ANEB-001 for the Treatment of Acute Cannabinoid Overdose (Business Wire)
Oct-12-21 08:59AM	Overdose Unknown: How Anebulo Pharmaceuticals Is Working to Solve a Growing Marijuana Overdose Problem (Benzinga)
Oct-05-21 08:00AM	Anebulo Pharmaceuticals to Participate in the Benzinga Cannabis Capital Conference in New York City (Business Wire)
Sep-27-21 07:41AM	The Unintended Consequences of Ever-Increasing Marijuana Potency (Benzinga)
Sep-22-21 04:05PM	Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Business Update (Business Wire)
Sep-20-21 08:13AM	Cannabis Edibles are Leading to More Negative Outcomes in Cannabis Users (Benzinga)
Sep-13-21 08:00AM	CB1 Antagonists as a Solution to the Complicated Problems of Cannabis Over-intoxication (Benzinga)
08:00AM	Anebulo Pharmaceuticals Announces Completion of Manufacturing of ANEB-001 Capsules for Upcoming Phase 2 Clinical Trial (Business Wire)
Sep-07-21 08:00AM	Anebulo Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (Business Wire)
07:04AM	Anebulo is Developing an Antidote to Cannabis Intoxication (Benzinga)
Aug-23-21 08:31AM	Cannabis Legalization is Driving an Increase in Related ER Visits (Benzinga)
Aug-16-21 08:39AM	Alcohol, Cannabis and Synergistic Risk (Benzinga)
Aug-12-21 08:00AM	Anebulo Pharmaceuticals Announces Formation of Scientific Advisory Board, Names First Two Members (Business Wire)
Aug-09-21 08:01AM	Cannabis Over-Intoxication Results in Millions of Visits to the ER per Year (Benzinga)
Aug-08-21 03:23AM	Here's What Anebulo Pharmaceuticals, Inc.'s (NASDAQ:ANEB) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Aug-03-21 02:40PM	The Underappreciated Risk Of Pediatric Cannabis Overdose (Benzinga) -6.17%
Jul-26-21 08:02AM	The Danger of Synthetic Cannabinoids (Benzinga)
Jul-12-21 08:22AM	The Dark Side of Cannabis Legalization and one Biotech Company's Solution (Benzinga) +5.02%
Jun-21-21 04:05PM	Anebulo Pharmaceuticals Reports Recent Business Highlights and Announces Third Quarter Fiscal Year 2021 Financial Results (Business Wire)
May-06-21 08:00PM	Anebulo Pharmaceuticals Announces Pricing of Initial Public Offering (Business Wire)

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
English Aron R.	Director	Dec 23 '24	Buy	0.99	10,101,010	10,000,000	15,467,300	Dec 26 04:15 PM

FSTR

L.B. Foster Co

LFCR

Lifecore Biomedical Inc

CULP

Culp Inc

ANEB

Anebulo Pharmaceuticals Inc

Upgrade your FINVIZ experience